Prevention of coronary heart disease: incremental cost effectiveness raises issues.
D003327:Coronary Disease / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics*; D019821:Simvastatin / Q000191:economics*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D019821:Simvastatin